National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

tyrosine kinase inhibitor BIBF 1120 (TY-ruh-seen KY-nayz in-HIH-bih-ter...)

 A substance being studied in the treatment of some types of cancer. Tyrosine kinase inhibitor BIBF 1120 blocks enzymes needed for cells to grow, and may prevent the growth of new blood vessels that tumors need to grow. It is a type of tyrosine kinase inhibitor and a type of antiangiogenesis agent. Also called BIBF 1120.



Previous Definitions:tympanites, type 3 serotonin receptor antagonist, type C thymoma, tyrosinase peptide, tyrosine kinase inhibitor
Next Definitions:TZT-1027, ubiquinone, UCN-01, UFT, Uftoral

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov